Re: Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
CCBYNCOpen access
Rapid response to:
Research
Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
Re: Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
We thank Mara N. Villanueva for correcting an error in the paper.
In the EINSTEIN studies cited, patients randomized to rivaroxaban received 15mg bid for three weeks followed by 20mg qd.
Rapid Response:
Re: Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
We thank Mara N. Villanueva for correcting an error in the paper.
In the EINSTEIN studies cited, patients randomized to rivaroxaban received 15mg bid for three weeks followed by 20mg qd.
Competing interests: No competing interests